SEC 13F Intelligence

Consonance Capital Management LP / OVID

Consonance Capital Management LP’s Ovid Therapeutics Inc Position

Does Consonance Capital Management LP own Ovid Therapeutics Inc (OVID)? Not currently — the last reported position was 2.57M shares worth $19M in Q2 2020; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$19M
Q2 2020
Shares
2.57M
% of Portfolio
+1.14%
Quarters Held
3
position exited

Position History OVID

Reported value by quarter
Q4 ’19: $12MQ4 ’19Q1 ’20: $8MQ1 ’20Q2 ’20: $19MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20202.57M$19M+1.14%
Q1 20202.58M$8M+0.57%
Q4 20192.89M$12M+0.73%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of OVID.